KLK5
Kallikrein-5
Also known as: KLK-L2, KLK5_HUMAN, SCTE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y337
- Gene
- KLK5
- Ensembl
- ENSG00000167754
- Chromosome
- 19
- Canonical length
- 293 aa
- Protein class
- Cancer-related genes, Enzymes, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its expression is up-regulated by estrogens and progestins. The encoded protein is secreted and may be involved in desquamation in the epidermis. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q9Y337|KLK5
1 MATARPPWMW VLCALITALL LGVTEHVLAN NDVSCDHPSN TVPSGSNQDL GAGAGEDARS
61 DDSSSRIING SDCDMHTQPW QAALLLRPNQ LYCGAVLVHP QWLLTAAHCR KKVFRVRLGH
121 YSLSPVYESG QQMFQGVKSI PHPGYSHPGH SNDLMLIKLN RRIRPTKDVR PINVSSHCPS
181 AGTKCLVSGW GTTKSPQVHF PKVLQCLNIS VLSQKRCEDA YPRQIDDTMF CAGDKAGRDS
241 CQGDSGGPVV CNGSLQGLVS WGDYPCARPN RPGVYTNLCK FTKWIQETIQ ANSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLK5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 196 nTPM
Expression across tissuesHPA
Tissue
- skin: 196 nTPM
- breast: 28 nTPM
- salivary gland: 24 nTPM
- esophagus: 22 nTPM
- cervix: 21 nTPM
- testis: 13 nTPM
Single-cell type
- late spermatids: 352 nCPM
- early spermatids: 154 nCPM
- breast secretory cells: 153 nCPM
- breast myoepithelial cells: 103 nCPM
- esophageal apical cells: 72 nCPM
- salivary duct cells: 69 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 2.6 nTPM
- cerebral cortex: 2.3 nTPM
- amygdala: 1.7 nTPM
- basal ganglia: 1.6 nTPM
- midbrain: 1.4 nTPM
- pons: 1.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amelogenesis
- antibacterial peptide biosynthetic process
- cornification
- epidermis development
- extracellular matrix disassembly
- positive regulation of G protein-coupled receptor signaling pathway
- protein maturation
- proteolysis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLK5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLK5 as an antibody target. Whether an autoantibody or antibody against KLK5 could matter depends on whether native KLK5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLK5 is annotated as secreted, so native KLK5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label KLK5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...